Hollsteen
← Everpure

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2016: $584M · 10-Q 0001564590-15-011439 filed Dec 11, 2015Equity incl. NCI · Q4 FY2016: $563M · 10-K 0001564590-16-015322 filed Mar 25, 2016Equity incl. NCI · Q1 FY2017: $541M · 10-Q 0001564590-16-020289 filed Jun 3, 2016Equity incl. NCI · Q2 FY2017: $514M · 10-Q 0001628280-16-019406 filed Sep 6, 2016Equity incl. NCI · Q3 FY2017: $478M · 10-Q 0001628280-16-022007 filed Dec 13, 2016Equity incl. NCI · Q4 FY2017: $537M · 10-K 0001628280-19-003437 filed Mar 26, 2019Equity incl. NCI · Q1 FY2018: $465M · 10-Q 0001628280-17-006263 filed Jun 7, 2017Equity incl. NCI · Q2 FY2018: $445M · 10-Q 0001628280-17-009061 filed Sep 5, 2017Equity incl. NCI · Q3 FY2018: $459M · 10-Q 0001628280-17-012265 filed Dec 8, 2017Equity incl. NCI · Q4 FY2018: $574M · 10-K 0001628280-19-003437 filed Mar 26, 2019Equity incl. NCI · Q1 FY2019: $632M · 10-Q 0001628280-18-007756 filed Jun 8, 2018Equity incl. NCI · Q2 FY2019: $644M · 10-Q 0001628280-18-011594 filed Sep 4, 2018Equity incl. NCI · Q3 FY2019: $702M · 10-Q 0001628280-18-014872 filed Dec 6, 2018Equity incl. NCI · Q4 FY2019: $738M · 10-K 0001628280-19-003437 filed Mar 26, 2019Equity incl. NCI · Q1 FY2020: $744M · 10-Q 0001628280-19-007753 filed Jun 7, 2019Equity incl. NCI · Q2 FY2020: $738M · 10-Q 0001628280-19-011331 filed Aug 30, 2019Equity incl. NCI · Q3 FY2020: $778M · 10-Q 0001628280-19-014877 filed Dec 9, 2019Equity incl. NCI · Q4 FY2020: $830M · 10-K 0001628280-20-004133 filed Mar 27, 2020Equity incl. NCI · Q1 FY2021: $757M · 10-Q 0001628280-20-009289 filed Jun 11, 2020Equity incl. NCI · Q2 FY2021: $746M · 10-Q 0001628280-20-013458 filed Sep 11, 2020Equity incl. NCI · Q3 FY2021: $735M · 10-Q 0001628280-20-017299 filed Dec 9, 2020Equity incl. NCI · Q4 FY2021: $750M · 10-K 0001628280-21-005538 filed Mar 25, 2021Equity incl. NCI · Q1 FY2022: $715M · 10-Q 0001628280-21-011838 filed Jun 8, 2021Equity incl. NCI · Q2 FY2022: $697M · 10-Q 0001628280-21-018247 filed Sep 8, 2021Equity incl. NCI · Q3 FY2022: $724M · 10-Q 0001628280-21-024638 filed Dec 7, 2021Equity incl. NCI · Q4 FY2022: $754M · 10-K 0001628280-22-008643 filed Apr 7, 2022Equity incl. NCI · Q1 FY2023: $727M · 10-Q 0001628280-22-017288 filed Jun 16, 2022Equity incl. NCI · Q2 FY2023: $761M · 10-Q 0001628280-22-024939 filed Sep 15, 2022Equity incl. NCI · Q3 FY2023: $841M · 10-Q 0001628280-22-031956 filed Dec 15, 2022Equity incl. NCI · Q4 FY2023: $941M · 10-K 0001628280-23-010275 filed Apr 3, 2023Equity incl. NCI · Q1 FY2024: $906M · 10-Q 0001628280-23-022333 filed Jun 16, 2023Equity incl. NCI · Q2 FY2024: $986M · 10-Q 0001628280-23-032228 filed Sep 14, 2023Equity incl. NCI · Q3 FY2024: $1.1B · 10-Q 0001628280-23-041629 filed Dec 15, 2023Equity incl. NCI · Q4 FY2024: $1.3B · 10-K 0001628280-24-013860 filed Apr 1, 2024Equity incl. NCI · Q1 FY2025: $1.4B · 10-Q 0001628280-24-027955 filed Jun 13, 2024Equity incl. NCI · Q2 FY2025: $1.5B · 10-Q 0001628280-24-040066 filed Sep 11, 2024Equity incl. NCI · Q3 FY2025: $1.4B · 10-Q 0001628280-24-050852 filed Dec 12, 2024Equity incl. NCI · Q4 FY2025: $1.3B · 10-K 0001628280-25-015044 filed Mar 27, 2025Equity incl. NCI · Q1 FY2026: $1.2B · 10-Q 0001628280-25-030567 filed Jun 11, 2025Equity incl. NCI · Q2 FY2026: $1.3B · 10-Q 0001474432-25-000046 filed Sep 10, 2025Equity incl. NCI · Q3 FY2026: $1.4B · 10-Q 0001474432-25-000065 filed Dec 10, 2025Equity incl. NCI · Q4 FY2026: $1.4B · 10-K 0001474432-26-000027 filed Mar 25, 2026Equity incl. NCI · Q1 FY2027: $1.4B · 10-Q 0001474432-26-000061 filed Jun 5, 2026Equity incl. NCI · Q2 FY2027: $1.5B · 10-Q 0001474432-26-000088 filed Sep 4, 20264591,541584Q1 FY2016Q2 FY2027Q3 FY2018
$MEquity incl. NCI · Q3 FY2017: $478M · 10-Q 0001628280-16-022007 filed Dec 13, 2016Equity incl. NCI · Q4 FY2017: $537M · 10-K 0001628280-19-003437 filed Mar 26, 2019Equity incl. NCI · Q1 FY2018: $465M · 10-Q 0001628280-17-006263 filed Jun 7, 2017Equity incl. NCI · Q2 FY2018: $445M · 10-Q 0001628280-17-009061 filed Sep 5, 2017Equity incl. NCI · Q3 FY2018: $459M · 10-Q 0001628280-17-012265 filed Dec 8, 2017Equity incl. NCI · Q4 FY2018: $574M · 10-K 0001628280-19-003437 filed Mar 26, 2019Equity incl. NCI · Q1 FY2019: $632M · 10-Q 0001628280-18-007756 filed Jun 8, 2018Equity incl. NCI · Q2 FY2019: $644M · 10-Q 0001628280-18-011594 filed Sep 4, 2018459644478Q3 FY2017Q2 FY2019Q3 FY2018
Q3 FY2018
459$M
All values (44)
PeriodValue ($M)Status
Q2 FY20271,541reported
Q1 FY20271,442reported
Q4 FY20261,446reported
Q3 FY20261,403reported
Q2 FY20261,319reported
Q1 FY20261,244reported
Q4 FY20251,306reported
Q3 FY20251,411reported
Q2 FY20251,453reported
Q1 FY20251,374reported
Q4 FY20241,270reported
Q3 FY20241,148reported
Q2 FY2024986reported
Q1 FY2024906reported
Q4 FY2023941reported
Q3 FY2023841reported
Q2 FY2023761reported
Q1 FY2023727reported
Q4 FY2022754reported
Q3 FY2022724reported
Q2 FY2022697reported
Q1 FY2022715reported
Q4 FY2021750reported
Q3 FY2021735reported
Q2 FY2021746reported
Q1 FY2021757reported
Q4 FY2020830reported
Q3 FY2020778reported
Q2 FY2020738reported
Q1 FY2020744reported
Q4 FY2019738reported
Q3 FY2019702reported
Q2 FY2019644reported
Q1 FY2019632reported
Q4 FY2018574reported
Q3 FY2018459reported
Q2 FY2018445reported
Q1 FY2018465reported
Q4 FY2017537reported
Q3 FY2017478reported
Q2 FY2017514reported
Q1 FY2017541reported
Q4 FY2016563reported
Q3 FY2016584reported
Q1 FY2016 – Q2 FY2016–missing (2 periods): No verified SEC value extracted, although the company reports this metric in other periods.

Show reported periods only · CSV with all sources · Technical ID: equity_total

More metrics for Everpure

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$459M
Period
Q3 FY2018, ended Oct 31, 2017 · as of Oct 31, 2017 (balance as of date, not a sum)
Source
10-Q, filed Dec 8, 2017 · 0001628280-17-012265
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$459MDec 8, 201710-Q 0001628280-17-012265reported · confidence 1. · current